Navigation Links
AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients
Date:10/6/2010

WILMINGTON, Del., Oct. 6 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that it is providing medicines at no cost to qualifying patients at the Primary Care Center Pharmacy in Sacramento, California.

(Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO)

AstraZeneca's partnership with the Sacramento County Pharmacy is an expansion of its AZ&Me™ Prescription Savings program that provides medicines at no cost to health facilities around the country. The Sacramento County Pharmacy is the ninth organization in California to join the program.

"The partnership with Sacramento County will help patients who might otherwise go without the medicines they need," said Jennifer McGovern, director, patient assistance programs, AstraZeneca Pharmaceuticals LP.

The Primary Care Center Pharmacy provides pharmaceuticals and medical supplies to nearly all departments within Sacramento County, dispensing an average of 1,200 prescriptions to patients per day.  Over the last eight years, the pharmacy's free drug programs have grown from one program with annual savings of $300,000 to 16 programs with annual savings in excess of $4.4 million. Approximately 25,000 uninsured patients benefit from the program.

"Working with AstraZeneca, the pharmacy will be able to get medicines to the people who need them, while focusing our resources on delivering programs and services to residents," said Steve Golka, director of pharmacy services, County of Sacramento.

Carrie's Touch, an organization that educates and empowers African-American women living with breast cancer in the Greater Sacramento area, praised the collaboration.

"I was fortunate enough to personally benefit from AZ&Me after losing my job and medical insurance," said Rev. Tammie Denyse, Carrie's Touch founder and president. "Without the support of this program, I would not have been able to receive my cancer medicine during this critical point in my treatment process. I am grateful this program exists."

Sacramento County Supervisor Roger Dickinson said, "AstraZeneca's commitment to providing free medicine is a crucial part of getting Sacramentans the care they need during tough economic times.  Many low-income workers don't have access to employer-sponsored health insurance and others lost coverage when they became unemployed during the recession.  Donated medicine ensures people get needed care and relieves financial pressure on an overburdened county health system."

In 2009, AstraZeneca provided more than $27.7 million in savings to more than 15,900 patients in California under its prescription savings programs – known as AZ&Me. Nationally, the company helped more than 507,000 patients save $769.6 million on their medicines.

About AZ&Me Prescription Savings Program for Healthcare Facilities

AZ&Me™ Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve the uninsured. The program is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual or $60,000 for a family of four.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines.  As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZeneca is a $14.8 billion healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit www.astrazeneca-us.com or call 1-800-AZandMe (292-6363). 


'/>"/>
SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
2. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
3. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
4. FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZenecas SYMBICORT
5. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
6. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
7. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
8. Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
9. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
10. AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
11. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):